Seres I - Search Results

1

Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.

Harangi M, Seres I, Varga Z, Emri G, Szilvássy Z, Paragh G, Remenyik E. Harangi M, et al. Among authors: seres i. Eur J Clin Pharmacol. 2004 Dec;60(10):685-91. doi: 10.1007/s00228-004-0820-6. Epub 2004 Oct 14. Eur J Clin Pharmacol. 2004. PMID: 15490140 Clinical Trial.

2

Transmembrane signaling changes with aging.

Fülöp T Jr, Barabás G, Varga Z, Csongor J, Hauck M, Szücs S, Seres I, Mohacsi A, Kékessy D, Despont JP, et al. Fülöp T Jr, et al. Among authors: seres i. Ann N Y Acad Sci. 1992 Dec 26;673:165-71. doi: 10.1111/j.1749-6632.1992.tb27449.x. Ann N Y Acad Sci. 1992. PMID: 1485715

3

Age-dependent changes in transmembrane signalling: identification of G proteins in human lymphocytes and polymorphonuclear leukocytes.

Fulop T Jr, Barabas G, Varga Z, József C, Csabina S, Szucs S, Seres I, Szikszay E, Jeney Z, Penyige A. Fulop T Jr, et al. Among authors: seres i. Cell Signal. 1993 Sep;5(5):593-603. doi: 10.1016/0898-6568(93)90054-p. Cell Signal. 1993. PMID: 8312135

4

[Granulocyte function and lipid peroxidation in untreated patients with hyperlipoproteinemia].

Varga Z, Paragh G, Kárpáti I, Seres I, Buris L, Kakuk G. Varga Z, et al. Among authors: seres i. Orv Hetil. 1997 Sep 7;138(36 Suppl 2):2301-4. Orv Hetil. 1997. PMID: 9340576 Hungarian.

5

The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia.

Paragh G, Seres I, Balogh Z, Varga Z, Kárpáti I, Mátyus J, Ujhelyi L, Kakuk G. Paragh G, et al. Among authors: seres i. Nephron. 1998 Oct;80(2):166-70. doi: 10.1159/000045161. Nephron. 1998. PMID: 9736814

6

Altered signal pathway in granulocytes from patients with hypercholesterolemia.

Paragh G, Kovács E, Seres I, Keresztes T, Balogh Z, Szabó J, Teichmann F, Fóris G. Paragh G, et al. Among authors: seres i. J Lipid Res. 1999 Sep;40(9):1728-33. J Lipid Res. 1999. PMID: 10484621 Free article.

7

Serum paraoxonase activity changes in uremic and kidney-transplanted patients.

Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G. Paragh G, et al. Among authors: seres i. Nephron. 1999;83(2):126-31. doi: 10.1159/000045489. Nephron. 1999. PMID: 10516491 Clinical Trial.

8

Which parameters affect cytosolic free calcium in polymorphonuclear leukocytes of haemodialysis patients?

Kárpáti I, Seres I, Mátyus J, Ben T, Paragh G, Varga Z, Kakuk G. Kárpáti I, et al. Among authors: seres i. Nephrol Dial Transplant. 2001 Jul;16(7):1409-15. doi: 10.1093/ndt/16.7.1409. Nephrol Dial Transplant. 2001. PMID: 11427633 Clinical Trial.

9

Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?

Balogh Z, Seres I, Harangi M, Kovács P, Kakuk G, Paragh G. Balogh Z, et al. Among authors: seres i. Diabetes Metab. 2001 Nov;27(5 Pt 1):604-10. Diabetes Metab. 2001. PMID: 11694861 Clinical Trial.

10

Determination of DNA damage induced by oxidative stress in hyperlipidemic patients.

Harangi M, Remenyik E E, Seres I, Varga Z, Katona E, Paragh G. Harangi M, et al. Among authors: seres i. Mutat Res. 2002 Jan 15;513(1-2):17-25. doi: 10.1016/s1383-5718(01)00285-6. Mutat Res. 2002. PMID: 11719086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters